Immunochemical and proteomic analysis of covalent adducts formed by quinone methide tumor promoters in mouse lung epithelial cell lines

Chemical Research in Toxicology

Volumn 18, Issue 10, 2005, Pages 1575-1585

  Meier, Brent W ^a   Gomez, Jose D ^a   Zhou, Angela ^a   Thompson, John A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; ANTIOXIDANT; BENZYL DERIVATIVE; BETA ACTIN; BETA TUBULIN; BUTYLCRESOL; CALCYCLIN; CALVASCULIN; CARBENE; CELL PROTEIN; CYSTEINE; CYTOSKELETON PROTEIN; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE P1; HEAT SHOCK PROTEIN 90 ALPHA; HEAT SHOCK PROTEIN 90 BETA; HISTIDINE; HYDROXYL GROUP; LYSINE; PHENOL DERIVATIVE; POLYCLONAL ANTIBODY; PROFILIN I; QUINONE DERIVATIVE; SULFIDE; THIOL GROUP; TOLUENE DERIVATIVE; TUBULIN; UBIQUITIN CONJUGATING ENZYME; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIMENTIN;

ALKYLATION; ANIMAL CELL; ARTICLE; CARBOHYDRATE METABOLISM; CARCINOGENESIS; CELL TRANSFORMATION; CONJUGATE; CONTROLLED STUDY; COVALENT BOND; DATA BASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; LUNG ALVEOLUS EPITHELIUM; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METABOLITE; MICHAEL ADDITION; MOUSE; NONHUMAN; NUCLEIC ACID SYNTHESIS; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN TARGETING; PROTEOMICS; RNA PROCESSING; TUMOR CELL LINE; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

ANIMALS; ANTIBODIES; BUTYLATED HYDROXYTOLUENE; CARCINOGENS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CYTOSKELETAL PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; GLUTATHIONE S-TRANSFERASE PI; INDOLES; LUNG; MICE; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEOMICS; QUINONES;

ANIMALIA;

EID: 27144456873     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx050108y     Document Type: Article

References (62)

1. Pitot, H. C. (2002) Fundamentals of Oncology, 4th ed., pp 223-272, Marcel Dekker, New York.
2. Kinnula, V. L., Paakko, P., and Soini, Y. (2004) Antioxidant enzymes and redox regulating thiol proteins in malignancies of human lung. FEBS Lett. 569, 1-6.
3. Klaunig, J. E., and Kamendulis, L. M. (1999) Mechanisms of cancer chemoprevention in hepatic carcinogenesis: Modulation of focal lesion growth in mice. Toxicol. Sci. 52 (Suppl.), 101-106.
4. Zhao, J., Lahiri-Chatterjee, M., Sharma, Y., and Agarwal, R. (2000) Inhibitory effect of a flavonoid antioxidant silymarin on benzoyl peroxide-induced tumor promotion, oxidative stress and inflammatory responses in SENCAR mouse skin. Carcinogenesis 21, 811-816.
5. Malkinson, A. M., Koski, K. M., Evans, W. A., and Festing, M. F. W. (1997) Butylated hydroxytoluene exposure is necessary to induce lung tumors in BALB mice treated with 3-methylcholanthrene. Cancer Res. 57, 2832-2834.
6. Witschi, H., Malkinson, A. M., and Thompson, J. A. (1989) Metabolism and pulmonary toxicity of butylated hydroxytoluene (BHT). Pharmacol. Ther. 42, 89-113.
7. Thompson, J. A., Carlson, T. J., Sun, Y., Dwyer-Nield, L, and Malkinson, A. M. (2001) Studies using structural analogues and inbred strain differences to support a role for quinone methide metabolites of butylated hydroxytoluene (BHT) in mouse lung tumor promotion. Toxicology 160, 197-205.
8. Kupfer, R., Dwyer-Nield, L. D., Malkinson, A. M., and Thompson, J. A. (2002) Lung toxicity and tumor promotion by hydroxylated derivatives of 2,6-di-tert-butyl-4-methylphenol (BHT) and 2-tert-butyl-4-methyl-6-iso- propylphenol: Correlation with quinone methide reactivity. Chem. Res. Toxicol. 15, 1106-1112.
9. Guyton, K. Z., Bhan, P., Kuppusamy, P., Zweier, J. L., Trush, M. A., and Kensler, T. W. (1991) Free radical-derived quinone methide mediates skin tumor promotion by butylated hydroxytoluene hydroperoxide: Expanded role for electrophiles in multistage carcinogenesis. Proc. Natl. Acad. Sci. U.S.A 88, 946-950.
10. Boberg, E. W., Liem, A., Miller, E. C., and Miller, J. A., (1987) Inhibition by pentachlorophenol of the initiating and promoting activities of 1′-hydroxysafrole for the formation of enzyme-altered foci and tumors in rat liver. Carcinogenesis 8, 531-539.
11. Kensler, T., Guyton, K., Egner, P., McCarthy, T., Lesko, S., and Akman, S. (1995) Role of reactive intermediates in tumor promotion and progression. Prog. Clin. Biol. Res. 391, 103-116.
12. Nakagawa, Y., Hiraga, K., and Suga, T. (1983) On the mechanism of covalent binding of butylated hydroxytoluene to microsomal protein. Biochem. Pharmacol. 32, 1417-1421.
13. Reed, M., and Thompson, D. C. (1997) Immunochemical visualization and identification of rat liver proteins adducted by 2,6-di-tert-butyl-4- methylphenol (BHT). Chem. Res. Toxicol. 10, 1109-1117.
14. Rombach, E. M., and Hanzlik, R. P. (1997) Detection of benzoquinone adducts to rat liver protein sulfhydryl groups using specific antibodies. Chem. Res. Toxicol. 10, 1407-1411.
15. Wakazono, H., Gardner, I., Eliasson, E., Coughtrie, M. W. H., Kenna, J. G., and Caldwell, J. (1998) Immunochemical identification of hepatic protein adducts derived from estragole. Chem. Res. Toxicol. 11, 863-872.
16. Gardner, I., Leeder, S. J., Chin, T., Zahid, N., and Uetrecht, J. P. (1998) A comparison of the covalent binding of clozapine and olanzapine to human neutrophils in vitro and in vivo. Mol. Pharmacol. 53, 999-1008.
17. Qiu, Y., Benet, L. Z., and Burlingame, A. L. (1998) Identification of the hepatic protein targets of reactive metabolites of acetaminophen in vivo in mice using two-dimensional gel electrophoresis and mass spectrometry. J. Biol. Chem. 273, 17940-17953.
18. Lamé, M. W., Jones, A. D., Wilson, D. W., Dunston, S. K., and Segall, H. J. (2000) Protein targets of monocrotaline pyrrole in pulmonary artery endothelial cells. J. Biol. Chem. 275, 29091-29099.
19. Lin, C. Y., Isbell, M. A., Morin, D., Boland, B. C., Salerai, M. R., Jewell, W. T., Weir, A. J., Fanucchi, M. V., Baker, G. L., Plopper, C. G., and Buckpitt, A. R. (2005) Characterization of a structurally intact in situ lung model and comparison of naphthalene protein adducts generated in this model vs lung microsomes. Chem. Res. Toxicol. 18, 802-813.
20. Malkinson, A. M., Dwyer-Nield, L. D., Rice, P. L., and Dinsdale, D. (1997) Mouse lung epithelial cell lines-tools for the study of differentiation and the neoplastic phenotype. Toxicology 123, 53-100.
21. Bentel, J. M., Lykke, A. W. J., and Smith, G. J. (1985) Cloned murine nonmalignant spontaneously transformed and chemical tumor-derived cell lines related to the type 2 pneumocyte. Cell Biol. Int. Rep. 9, 1115-1122.
22. Lemercier, J. N., Meier, B., Gomez, J., and Thompson, J. A. (2004) Inhibition of glutathione S-transferase P1-1 in mouse lung epithelial cells by the tumor promoter 2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone (BHT-quinone methide): Protein adducts investigated by electrospray mass spectrometry. Chem. Res. Toxicol. 17, 1675-1683.
23. Adler, V., Yin, Z., Fuchs, S. Y., Benezra, M., Rosario, L., Tew, K. D., Pincus, M. R., Sardana, M., Henderson, C. J., Wolf, C. R., Davis, R. J., and Ronai, Z. (1999) Regulation of JNK signaling by GSTp. EMBO J. 18, 1321-1334.
24. Bolton, J. L., Valerio, L. G., and Thompson, J. A. (1992) The enzymatic and chemical reactivity of quinone methides correlate with alkylphenol-induced toxicity in rat hepatocytes. Chem. Res. Toxicol. 5, 816-822.
25. Bolton, J. L., Turnipseed, S. B., and Thompson, J. A. (1997) Influence of quinone methide reactivity on the alkylation of thiol and amino groups in proteins: studies utilizing amino acid and peptide models. Chem.-Biol. Interact. 107, 185-200.
26. Dwyer-Nield, L. D., Thompson, J. A., Peljak, G., Squier, M. K., Barker, T. D., Parkinson, A., Cohen, J. J., Dinsdale, D., and Malkinson, A. M. (1998) Selective induction of apoptosis in mouse and human lung epithelial cell lines by the tert-butyl hydroxylated metabolite of butylated hydroxytoluene: a proposed role in tumor promotion. Toxicology 130, 115-127.
27. Sun, Y., Dwyer-Nield, L. D., Malkinson, A. M., Zhang, Y. L., and Thompson, J. A. (2003) Responses of tumorigenic and nontumorigenic mouse lung epithelial cell lines to electrophilic metabolites of the tumor promoter butylated hydroxytoluene. Chem.-Biol. Interact. 145, 41-51.
28. McCracken, P. G., Bolton, J. L., and Thatcher, G. R. J. (1997) Covalent modification of proteins and peptides by the quinone methide from 2-tert-butyl-4,6-dimethylphenol: Selectivity and reactivity with respect to competitive hydration. J. Org. Chem. 62, 1820-1825.
29. Hartley, D. P., Kroll, D. J., and Petersen, D. R. (1997) Prooxidant-initiated lipid peroxidation in isolated rat hepatocytes: Detection of 4-hydroxynonenal- and malondialdehyde-protein adducts. Chem. Res. Toxicol. 10, 895-905.
30. Rombach, E. M., and Hanzlik, R. P. (1999) Detection of adducts of bromobenzene 3,4-oxide with rat liver microsomal protein sulfhydryl groups using specific antibodies. Chem. Res. Toxicol. 12, 159-163.
31. Mancini, J. A., Waugh, R. J., Thompson, J. A., Evans, J. F., Zamboni, R., and Murphy, R. C. (1998) Structural characterization of the covalent attachment of leukotriene A3 to leukotriene A4 hydrolase. Arch. Biochem. Biophys. 354, 117-124.
32. Guo, Z., Wagner, C. R., and Hanna, P. E. (2004) Mass spectrometric investigation of the mechanism of inactivation of hamster arylamine N-acetyltransferase 1 by N-hydroxy-2-acetylaminofluorene. Chem. Res. Toxicol. 17, 275-286.
33. Carbone, D. L., Doorn, J. A., Kiebler, Z., Sampey, B. P., and Petersen, D. R. (2004) Inhibition of Hsp72-mediated protein refolding by 4-hydroxy-2-nonenal. Chem. Res. Toxicol. 17, 1459-1467.
34. Peebles, K. A., Duncan, M. W., Ruch, R. J., and Malkinson, A. M. (2003) Proteomic analysis of a neoplastic mouse lung epithelial cell line whose tumorigenicity has been abrogated by transfection with the gap junction structural gene for connexin 43, GJa1. Carcinogenesis 24, 651-657.
35. Tami, K., Satoh, K., Tsuchida, S., Hatayama, I., Maki, T., and Sato, K. (1990) Specific inactivation of glutathione S-transferases in class pi by SH-modifiers. Biochem. Biophys. Res. Commun. 167, 331-338.
36. Wood, Z. A., Schroder, E., Harris, J. R., and Poole, L. B. (2003) Structure, mechanism, and regulation of peroxiredoxins. Trends Biochem. Sci. 28, 32-40.
37. Castelli, C., Rivoltini, L., Rini, F., Belli, F., Testori, A., Maio, M., Mazzaferro, V., Coppa, J., Srivastava, P. K., and Parmiani, G. (2004) Heat shock proteins: Biological functions and clinical application as personalized vaccines for human cancer. Cancer Immunol. Immunother. 53, 227-233.
38. Zhang, H., and Burrows, F. (2004) Targeting multiple signal transduction pathways through inhibition of Hsp90. J. Mol. Med. 82, 488-499.
39. Okamoto, Y., Ozaki, T., Miyazaki, K., Aoyama, M., Miyazaki, M., and Nakagawara, A. (2003) UbcH10 Is the cancer-related E2 ubiquitin-conjugating enzyme. Cancer Res. 63, 4167-4173.
40. Shaw, P. E. (2002) Peptidly-prolyl isomerases: A new twist to transcription. EMBO Rep. 3, 521-526.
41. Gilbert, H. F. (1997) Protein disulfide isomerase and assisted protein folding. J. Biol. Chem. 272, 29399-29402.
42. Gomez-Puertas, P., Martin-Benito, J., Carrascosa, J. L., and Willison, K. R. (2004) The substrate recognition mechanisms in chaperonins. J. Mol. Recognit. 17, 85-94.
43. Li, L. S., Kim, H., Rhee, H., Kim, S. E., Shin, D. H., Chung, K. Y., Park, K., Paik, Y., Chang, J., and Kim, H. (2004) Proteomic analysis distinguishes basaloid carcinoma as a distinct subtype of nonsmall cell lung carcinoma. Proteomics 4, 3394-3400.
44. Feo, S., Arcuri, D., Piddini, E., Passantino, R., and Giallongo, A. (2000) ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: Relationship with Myc promoter-binding protein (MBP-1). FEBS Lett. 473, 47-52.
45. Goren, A., Levy, Y., Ronen, D., and Zick, Y. (2005) Cyclin-dependent kinase inhibitors and JNK act as molecular switches, regulating the choice between growth arrest and apoptosis induced by galectin-8. J. Biol. Chem. 10, 1074-1075.
46. Liu, F., and Rabinovich, G. A. (2005) Galectins as modulators of tumour progression. Nat. Rev. 5, 29-41.
47. Penuelas, S., Noe, V., and Ciudad, C. J. (2005) Modulation of IMPDH2, survivin, topoisomerase 1 and vimentin increases sensitivity to methotrexate in HT29 human colon cancer cells. FEBS J. 272, 696-710.
48. Wright, D. G., Boosalis, M., Malel, K., and Waraska, K. (2004) Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia Part II. In vitro studies. Leuk. Res. 28, 1137-1143.
49. Almgren, M. A. E., Henriksson, K. C. E., Fujimoto, J., and Chang, C. L. (2004) Nucleoside diphosphate kinase A/nm23-H1 promotes metastasis of NB69-derived human neuroblastoma. Mol. Cancer Res. 2, 387-394.
50. Hong, E. S., Yeung, A., Funchain, P., Slupska, M. M., and Miller, J. H. (2005) Mutants with temperature-sensitive defects in the Escherichia coli mismatch repair system: Sensitivity to mispairs generated in vivo. J. Bacteriol. 187, 840-846.
51. Fabrizi, L., Taylor, G. W., Canas, B., Boobis, A. R., and Edwards, R. J. (2003) Adduction of the chloroform metabolite phosgene to lysine residues of human histone H2B. Chem. Res. Toxicol. 16, 266-275.
52. Mai, A., Massa, S., Rotili, D., Cerbara, I., Valente, S., Pezzi, R., Simeoni, S., and Ragno, R. (2005) Histone deacetylation in epigenetics: An attractive target for anticancer therapy. Med. Res. Rev. 25, 261-309.
53. Fielding, P., Turnbull, L., Prime, W., Walshaw, M., and Field, J. K. (1999) Heterogeneous nuclear ribonucleoprotein A2/B1 upregulation in bronchial lavage specimens: A clinical marker of early lung cancer detection. Clin. Cancer Res. 5, 4048-4052.
54. He, Y., Brown, M. A., Rothnagel, J. A., Saunders, N. A., and Smith, R. (2005) Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation. J. Cell Sci. 118, 3173-3183.
55. Andersen, G. R., Nissen, P., and Nyborg, J. (2003) Elongation factors in protein biosynthesis. Trends Biochem. Sci. 28, 434-441.
56. Yin, X., Fontoura, B. M. A., Morimoto, T., and Carroll, R. B. (2003) Cytoplasmic complex of p53 and eEF2. J. Cell. Physiol. 196, 474-482.
57. Stoker, M. G. (1967) Transfer of growth inhibition between normal and virus-transformed cells: Autoradiographic studies using marked cells. J. Cell Sci. 2, 293-304.
58. Trosko, J. E., and Ruch, R. J. (2002) Gap junctions as targets for cancer chemoprevention and chemotherapy. Curr. Drug Targets 3, 465-482.
59. Guo, Y., Martinez-Williams, C., and Rannels, D. E. (2003) Gap junction-microtubule associations in rat alveolar epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 285, L1213-L1221.
60. Chipman, J. K., Mally, A., and Edwards, G. O. (2003) Disruption of gap junctions in toxicity and carcinogenicity. Toxicol. Sci. 71, 146-153.
61. Donato, R. (1999) Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim. Biophys. Acta 1450, 191-231.
62. Emberley, E. D., Murphy, L. C., and Watson, P. H. (2004) S100 proteins and their influence on pro-survival pathways in cancer. Biochem. Cell Biol. 82, 508-515.